Contact Us
Click here to contact Felicity Thomas,editor.
October 22, 2014
Glaucoma therapy Travoprost monotherapy effective for POAG Travoprost monotherapy has demonstrated long-term 24-hour efficacy for the treatment of primary open-angle glaucoma (POAG).More...
Meibomian gland dysfunction Topical loteprednol may aid in the treatment of MGD Patients with moderate and severe meibomian gland dysfunction (MGD) may benefit from topical loteprednol etabonate and eyelid scrubs with warm compresses, according to researchers in South Korea. More...
RP Genome Project UK charities drive retinal dystrophy consortium UK sight loss charities RP Fighting Blindness and Fight for Sight are joining forces to drive a project that will accelerate understanding of the genetic causes of inherited retinal dystrophies (IRD). More...
Products in Practice Issue 3
Real world experience of leading ophthalmic products.
Read more:
